Newamsterdam Pharma
Clinical trials sponsored by Newamsterdam Pharma, explained in plain language.
-
New combo pill slashes bad cholesterol in High-Risk patients
Disease control CompletedThis phase 3 study tested a daily pill that combines two drugs, obicetrapib and ezetimibe, in 407 adults with inherited high cholesterol or heart disease who were already on maximum cholesterol-lowering therapy. The goal was to see if the combination could further lower LDL (bad)…
Phase: PHASE3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated May 26, 2026 06:25 UTC
-
New Cholesterol-Lowering pill shows promise in major trial
Disease control CompletedThis study tested a new drug called obicetrapib in over 2,500 adults with high cholesterol or heart disease whose cholesterol was not well-controlled by their current medications. Participants took either the drug or a placebo pill daily for about 6 months. The main goal was to s…
Phase: PHASE3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated May 26, 2026 06:23 UTC